首页|早期动态Pcv-aCO2及Pcv-aCO2/Ca-cvO2监测对感染性休克患者预后评估的前瞻性临床研究

早期动态Pcv-aCO2及Pcv-aCO2/Ca-cvO2监测对感染性休克患者预后评估的前瞻性临床研究

扫码查看
目的 探究早期中心静脉与动脉二氧化碳分压差(Pcv-aCO2)、中心静脉与动脉二氧化碳分压差和动脉与中心静脉氧含量差的比值(Pcv-aCO2/Ca-cvO2)在感染性休克的预后评估中的价值.方法 选择 2018 年 10月至 2020 年 12 月间在宁夏医科大学总医院ICU收住的感染性休克患者 90 例,动态记录患者入ICU后第 1、2、3、5 天中心静脉和外周动脉血气分析数据.随访患者 28d预后,依据生存情况分为存活组(58 例)与死亡组(32 例).采用Logistic回归对感染性休克患者预后影响因素进行分析.采用受试者工作特征(ROC)曲线分析入院后 24h急性生理学和慢性健康状况评分系统Ⅱ(APACHEⅡ)评分、乳酸和Pcv-aCO2 对患者预后的预测价值.结果 感染性休克死亡组患者入ICU第 2、3 天的ScvO2 低于存活组(P<0.05).第 2、3 天的Pcv-aCO2高于存活组(P<0.05).死亡组入ICU第 1、2、3 天的乳酸值均高于存活组(P均<0.05).两组患者入ICU第 5 天ScvO2、乳酸及Pcv-aCO2 的差异均无统计学意义(P均>0.05).两组患者入ICU任何时相的Pcv-aCO2/Ca-cvO2值差异均无统计学意义(P均>0.05).以感染性休克患者的预后为因变量的Logistic回归分析,Pcv-aCO2 第 3天(OR=1.153,95%CI:1.005~1.323)、Pcv-aCO2 第 3 天(OR=1.369,95%CI:1.030~1.819)以及APACHEⅡ评分(OR=1.565,95%CI:1.285~1.906)是影响感染性休克患者死亡的独立危险因素(P<0.05).ROC曲线分析可得Pcv-aCO2(第 3 天)联合APACHE Ⅱ评分对于感染性休克病人的死亡的预测价值高于其单独的预测价值(AUC=0.727,P<0.001).结论 早期Pcv-aCO2、血乳酸、ScVO2 较Pcv-aCO2/Ca-cvO2 更好反应感染性休克疾病严重程度和预后.持续升高的Pcv-aCO2 对感染性休克预后预测价值更大.
A Prospective Clinical Study of Dynamic Pcv-aCO2 and Pcv-aCO2/Ca-cvO2 Ratio Monitoring in Evaluating the Prognosis of Patients with Septic Shock
Objective To investigate the value of central venous-arterial carbon dioxide partial pressure differ-ence(Pcv-aCO2),the ratio of central venous-arterial carbon dioxide partial pressure difference to arterial-cen-tral venous oxygen content difference(Pcv-aCO2/Ca-cvO2)and lactate in the prognostic assessment of septic shock.Methods A total of 90 patients with septic shock admitted to the ICU of General Hospital of Ningxia Medical University from October 2018 to December 2020,and their general clinical data were recorded.The central venous and peripheral arterial blood gas analysis data were dynamically record on the first,second,third,and fifth day after the patient entered the ICU.After 28 days of follow-up,the patients were divided into survivors group(58 cases)and a non-survivors group(32 cases)based on their survival status.Logistic regres-sion was used to analyze the prognostic factors of patients with septic shock.The predictive value of acute phys-iology and chronic health evaluation Ⅱ(APACHEⅡ)scores,lactate,and Pcv-aCO2 were analyzed for prognosis at 24 h after admission using the receiver operating characteristic(ROC)curve.Results ScvO2 was signifi-cantly lower in the septic shock non-survivors group than in the survivors group on days 2 and 3 of admission to the ICU(P<0.05).Pcv-aCO2 was significantly higher than that in the survivors group on days 2 and 3 of admis-sion to the ICU(P<0.05).The lactate values on days 1,2 and 3 of ICU admission were higher in the non-sur-vivors group than those in the survivors group(Pall<0.05).The levels of Pcv-aCO2/Ca-cvO2 at any time point of ICU stay were not significantly different between the non-survivors group and survivors group(P all>0.05).The differences in ScvO2,lactate and Pcv-aCO2 on day 5 of admission to ICU were not statistically significant in both groups(Pall>0.05).Univariate analysis and forward stepwise logistic regression analysis were performed using the 28-day mortality as the primary endpoint in septic shock patients.The findings showed that Pcv-aCO2 on day 2(OR=1.153,95%CI:1.005-1.323),Pcv-aCO2 on Day 3(OR=1.369,95%CI:1.030-1.819)and APACHE Ⅱ score on day 1 of ICU admission(OR=1.565,95%CI:1.285-1.906)were independent risk factors for mortality in patients with septic shock(P<0.05).ROC curve analysis revealed that Pcv-aCO2 on Day 3 of ICU admission combined with APACHE Ⅱ score has a higher predictive value in 28-Day mortality of septic shock patients(AUC=0.727,P<0.001).Conclusion Pcv-aCO2,blood lactic acid and ScVO2 are better than Pcv-a-CO2/Ca-cvO2 in reflecting the severity and prognosis of septic shock.The persistence of high Pcv-aCO2 is of greater value in predicting the prognosis of septic shock.

septic shockPcv-aCO2lactatePcv-aCO2/Ca-cvO2prognosis

孙新星、江坤、张珺、王晓红

展开 >

宁夏医科大学,银川 750004

南阳医学高等专科学校第一附属医院,南阳 473000

宁夏医科大学总医院重症医学科,宁夏医科大学第一临床医学院 银川 750004

感染性休克 中心静脉与动脉二氧化碳分压差 乳酸 中心静脉与动脉二氧化碳分压差和动脉与中心静脉氧含量差的比值

宁夏回族自治区重点研发计划项目

2021BEG03064

2024

宁夏医科大学学报
宁夏医科大学

宁夏医科大学学报

CSTPCD
影响因子:0.84
ISSN:1674-6309
年,卷(期):2024.46(1)
  • 22